Funder
National Natural Science Foundation of China
Ministry of Science and Technology of the People's Republic of China
Reference72 articles.
1. Cancer statistics;Siegel;CA A Cancer J. Clin.,2024
2. Breast cancer;Harbeck;Nat. Rev. Dis. Prim.,2019
3. A multicenter phase III prospective randomized trial of high-dose epirubicin in combination with cyclophosphamide (EC) versus docetaxel followed by EC in node-positive breast cancer;Vici;GOIM (Gruppo Oncologico Italia Meridionale) 9902 study, Ann Oncol,2012
4. Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37298 women with early breast cancer in 26 randomised trials;Gray;Lancet,2019
5. Acquired resistance to combined BET and CDK4/6 inhibition in triple-negative breast cancer;Ge;Nat. Commun.,2020
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献